Liu Sheng, Hua Yong-qiang, Sun Zhen-ping, Tan Song, Lu De-ming
Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Zhong Xi Yi Jie He Xue Bao. 2007 Mar;5(2):147-9.
To observe the effect of Ruyiping, a traditional Chinese compound herbal medicine composed of 5 Chinese herbs for removing toxic materials and dissipating nodules from Runing II, another traditional Chinese compound herbal medicine for treating breast cancer, in preventing recidivation and metastasis in breast cancer patients after operation.
Eighty patients with breast cancer after operation were randomly divided into Ruyiping group and Runing II group, and prescribed Ruyiping and Runing II on the basis of chemotherapy, radiotherapy and endocrine therapy respectively for two years.
There were two patients with metastasis and three patients lost to follow-up in Ruyiping group and three and two in Runing II group. The recidivation and metastasis rates were 5.41% and 7.89% respectively. The difference between the two groups was not statistically significant (P>0.05). The difference of disease-free survival time between the two groups was also not statistically significant.
The effect of Ruyiping in preventing recidivation and metastasis is similar to that of Runing II. Ruyiping is the essential component of Runing II for preventing recidivation and metastasis. The result provides some clinical evidences for the theory that "Yudu Pangcuan" (vestigial poison invasion elsewhere) is the essential pathogenesis of breast cancer's recidivation and metastasis and the utilization of "Sanjie Jiedu" (dispersing accumulation and detoxification) is the therapeutic principle in preventing recidivation and metastasis after operation.
观察由5味中药组成的具有解毒散结作用的中药复方制剂乳癖平对另一治疗乳腺癌的中药复方制剂乳宁Ⅱ预防乳腺癌患者术后复发转移的作用。
80例乳腺癌术后患者随机分为乳癖平组和乳宁Ⅱ组,分别在化疗、放疗及内分泌治疗基础上服用乳癖平和乳宁Ⅱ,疗程均为2年。
乳癖平组有2例发生转移,3例失访;乳宁Ⅱ组有3例发生转移,2例失访。复发转移率分别为5.41%和7.89%,两组差异无统计学意义(P>0.05)。两组无病生存时间差异也无统计学意义。
乳癖平预防复发转移的作用与乳宁Ⅱ相似,乳癖平是乳宁Ⅱ预防复发转移的核心组成部分。本研究结果为“余毒旁窜”是乳腺癌复发转移的核心病机、“散结解毒”是预防术后复发转移的治疗原则提供了临床依据。